A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Glisoxepide
Suvorexant
Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Glisoxepide
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Arbaclofen Placarbil.
Glisoxepide
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Arbaclofen Placarbil.
Glisoxepide
Rotigotine
Arbaclofen Placarbil may increase the sedative activities of Rotigotine.
Glisoxepide
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Arbaclofen Placarbil.
Glisoxepide
Paraldehyde
Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Glisoxepide
Methotrimeprazine
Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Fenoterol
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Carfilzomib.
Fenoterol
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Carfilzomib.
Fenoterol
Filgotinib
The serum concentration of Carfilzomib can be increased when it is combined with Filgotinib.
Fenoterol
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Carfilzomib.
Fenoterol
Inebilizumab
The risk or severity of infection can be increased when Carfilzomib is combined with Inebilizumab.
Fenoterol
Capmatinib
The serum concentration of Carfilzomib can be increased when it is combined with Capmatinib.
Fenoterol
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Carfilzomib.
Fenoterol
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Carfilzomib.
Fenoterol
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Carfilzomib.
Fenoterol
Lefamulin
Carfilzomib may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Fenoterol
Acetyldigoxin
Carfilzomib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Fenoterol
Metildigoxin
Carfilzomib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Fenoterol
Erdafitinib
The serum concentration of Carfilzomib can be increased when it is combined with Erdafitinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3